Gri Bio Inc (GRI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Operating Expenses | 11,977 | 8,235 | 11,387 | 2,239 | 9,259 |
| Operating Income | -11,977 | -8,235 | -11,387 | -2,239 | -9,259 |
| Interest Expense | 0 | 0 | 2,082 | 653 | 16 |
| Other Income | 21 | 28 | 432 | -325 | -28 |
| Pre-tax Income | -11,956 | -8,207 | -13,037 | -3,217 | -9,303 |
| Net Income Continuous | -11,956 | -8,207 | -13,037 | -3,217 | -9,303 |
| Net Income | $-11,956 | $-8,207 | $-13,037 | $-3,217 | $-9,303 |
| EPS Basic Total Ops | -121.80 | -1,545.55 | -140,562.70 | -154,560.50 | -1.42 |
| EPS Basic Continuous Ops | -121.80 | -1,253.55 | -140,562.80 | -154,486.10 | -1.42 |
| EPS Diluted Total Ops | -121.80 | -1,545.55 | -140,562.70 | -154,560.50 | -1.42 |
| EPS Diluted Continuous Ops | -121.80 | -1,253.55 | -140,562.80 | -154,486.10 | -1.42 |
| EPS Diluted Before Non-Recurring Items | -121.80 | -1,546.50 | -175,003.41 | -898,257.31 | N/A |
| EBITDA(a) | $-11,973 | $-8,231 | $-9,279 | $-2,019 | $-9,154 |